Company / Interest Expense
Edwards Lifesciences Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-$20.4M
FY2025
5-year range
-$20.4M / $19.2M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#44 of 44
Health Care
What the data says
Interest Expense changed -211% YoY in FY2025, a notable deviation from the 8-year average annual change of -25%.
Based on SEC 10-K filings.
-$20M in FY2025.
Improved from $19M to -$20M over the past 3 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 44This company -$20.4M Sector average $316.9M
▼
-106.4% below sector average
Key checks
Key Insights
- Ranks #44 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$20.4M | - |
| FY2024 | - | - |
| FY2023 | $18.4M | -4.2% |
| FY2022 | $19.2M | +4.3% |
| FY2021 | $18.4M | +16.5% |
| FY2020 | $15.8M | -23.7% |
| FY2019 | $20.7M | -30.8% |
| FY2018 | $29.9M | +28.9% |
| FY2017 | $23.2M | +20.8% |
| FY2016 | $19.2M | +11.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026